SCHEMBL6950669

SCHEMBL6950669

CCOC(OCC)c1ccc(CC(CO)(CO)Cc2ccc(Br)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ACHE P22303 6/20 0.40
PTGS2 P35354 6/20 0.40
BCHE P06276 5/20 0.40
PPARG P37231 3/20 0.34
PPARD Q03181 3/20 0.34
PPARA Q07869 3/20 0.34
GAA P10253 1/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
MEN1 O00255 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6948598 0.94 ACHE (0.44) ACHEPTGS2BCHEPPARGPPARA
SCHEMBL6944114 0.84 HTT (0.38) ACHEPTGS2BCHE
SCHEMBL508188 0.80 PTGS2 (0.50) ACHEPTGS2BCHEGAAKMT2A
SCHEMBL6952158 0.80 TAAR1 (0.39) KMT2AALDH1A1MEN1
SCHEMBL6947233 0.79 BCHE (0.44) ACHEPTGS2BCHEPPARGPPARD
SCHEMBL9721323 0.78 PTGS2 (0.49) ACHEPTGS2BCHEGAAKMT2A
SCHEMBL6944045 0.77 MEN1 (0.37) ACHEPTGS2BCHEPPARGPPARD
SCHEMBL14180221 0.75 ESR1 (0.45) ACHEPTGS2BCHEPPARGNPC1
SCHEMBL4738416 0.75 ACHE (0.50) ACHEPTGS2BCHEPPARGPPARA
SCHEMBL5728655 0.74 ACHE (0.44) ACHEPTGS2BCHENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1115729-B1 PHOSPHONIC ACID DERIVATIVES AS INHIBITORS OF PTP-1B MERCK FROSST CANADA INC (CA) 2003-02-19 EP disclosed
EP-1115729-A1 PHOSPHONIC ACID DERIVATIVES AS INHIBITORS OF PTP-1B Merck Frosst Canada & Co. (CA) 2001-07-18 EP disclosed
US-6174874-B1 ANTIDIABETIC,-CARCINOGENIC AGENTS; IMPROVING GLUCOSE TOLERANCE/INSULIN-SENSITIVITY; PREVENTING/TREATING OBESITY AND NEURODEGENERATIVE DISEASES; E.G. 1,3-BIS-((PHOSPHONODI-FLUOROMETHYL)PHENYL)-2-DICARBOXYPROPANE MERCK FROSST CANADA & CO. (CA) 2001-01-16 US disclosed
WO-2000017211-A1 PHOSPHONIC ACIDS DERIVATIVES AS INHIBITORS OF PTP-1B MERCK FROSST CANADA & CO. (CA) 2000-03-30 WO disclosed